Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

Novel GABA uptake inhibitors from Novo Nordisk

Dec. 18, 1996

Angiogenesis inhibitors under study at ADIR

Dec. 17, 1996

Dual-action compounds claimed by British Biotech

Dec. 17, 1996

New diuretics reported by Pharmacia & Upjohn

Dec. 17, 1996

Zeneca reports antiproliferative tyrosine kinase inhibitors

Dec. 17, 1996

New imaging agents for 19F MRI claimed by Molecular Biosystems

Dec. 17, 1996

New antiplatelet agents described by Thomae

Dec. 17, 1996

New antisense compounds reported by French investigators

Dec. 16, 1996

SKB reports new vaccine compositions

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.